Tradestie Institutional Equity Comparison Engine

SGP vs NVS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NVS Overall Edge

NVS Captures Institutional Edge (3โ€“1 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Novartis AG (NVS) driven by superior Valuation, Growth & Margin, Options & Structure while SGP counters with relative strength in Momentum & Technical. Fundamentally, SGP trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus NVS at 16.1x Forward P/E and 34.0% operating margin (+4.7% YoY). In options structure, SGP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NVS sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NVS
SGP N/M vs NVS 16.1x Fwd P/E
Growth & Margin Winner NVS
Op Margin N/A vs 34.0% ยท YoY N/A vs +4.7%
Momentum & Technical Winner SGP
1Y +22.1% vs +21.4% ยท 52W Pos 66% vs 78%
Options & Structure Winner NVS
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (6th %ile IV)
SGP US Equity
SGP
Institutional Equity
$32.24
-1.95% 1D
Market Cap N/A
1M Return +34.33%
1Y Return +22.12%
Forward P/E N/M
Unified AI Score
39.3 / 100 SELL
Tech 15.0 Fund 45.0 Flow 50.0 Mom 60.0
NVS NYSE
Novartis AG
Pharmaceutical Preparations
$160.20
-0.19% 1D
Market Cap $303.1B
1M Return +6.36%
1Y Return +21.45%
Forward P/E 16.1x
Unified AI Score
43.7 / 100 HOLD
Tech 37.0 Fund 37.0 Flow 50.0 Mom 21.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SGP +22.12% NVS +21.45% Spread: +19.7 pp (SGP Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SGP TTM Op. Margin: N/A NVS TTM Op. Margin: 34.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SGP vs NVS. Trailing 12-month operating profitability (SGP N/A vs NVS 34.0%) and valuation multiples (SGP N/M vs NVS 16.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SGP (0) vs NVS (10)
Institutional Metric SGP NVS Criterion Row Winner
Market Capitalization Scale N/A $303.1B Larger Scale NVS
Trailing P/E Ratio Valuation N/M 30.6x Lower Multiple NVS
Forward P/E Ratio Valuation N/M 16.1x Lower Multiple NVS
Revenue Growth (YoY) Growth N/A +4.7% Higher Growth NVS
Operating Margin (TTM) Profitability N/A 34.0% Higher Margin NVS
Net Profit Margin Profitability N/A 17.5% Higher Margin NVS
Return on Equity (ROE) Capital Efficiency N/A 24.3% Higher ROE NVS
52-Week Range Position Momentum 66% ($17โ€“$40) 78% ($123โ€“$170) Stronger Trend NVS
Beta / 30D Volatility Risk Regime 1.38ฮฒ ยท 70% Vol 0.31ฮฒ ยท 27% Vol Lower Realized Risk NVS
Unified Institutional Score Composite Signal 39.3 / 100 (SELL) 43.7 / 100 (HOLD) Higher Composite NVS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SGP vs NVS Buy Guide
SGP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SGP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NVS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live NVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SGP nor NVS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.